Share

Blood Biomarkers Identified in Drug-Resistant Cancer Tumor Cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies. In a study published online this month in the journal Clinical Cancer Research, the authors reported that they isolated multiple key gene alterations...
Share

Case of the Month: Mineral Metabolism & Cancer

endocrine board review This issue highlights the 8th edition of EBR – a mock-exam with more than 240 clinical case questions. Hear expert commentary and read in-depth answer rationales. Available on the online store. A 34-year-old woman presents with nausea, vomiting, mental confusion, and dehydration. Her history is positive for a Wilms tumor as a child and uterine...
Share

A Pervasive Threat: The Danger of in utero BPA Exposure

breast cancer image A new study presented at ENDO 2016 revealed a possible link between bisphenol A exposure in utero to breast cancer later in life. In the process, the researchers created a new bioassay that can test chemicals much faster than typical animal studies. Almost every single person alive today has detectable amounts of endocrine-disrupting chemicals (EDCs)...
Share

Cautiously Optimistic: The Future of Pancreatic Cancer Treatments

pancreatic cancer patient As survival rates from pancreatic cancer slowly inch upward, a new drug therapy may offer patients a brighter outlook. For many decades, a diagnosis of pancreatic cancer has been associated with a dismal chance of survival. In 2008, the overall five-year relative survival rate climbed above 5% for the first time — reaching a high...
Share

Tumor Recall: A Thyroid Cancer Gets Reclassified

thyroid tumor image Literal headlines were made a few months ago when an encapsulated follicular variant of papillary thyroid carcinoma was classified as a non-cancerous thyroid tumor by an international panel of experts. As the debate rages on, all agree on one thing: more studies are needed. In April, the Journal of the American Medical Association Oncology (JAMA Oncology)...
Share

Could Metformin Reduce Cancer Death Risk?

Metformin, one of the most widely prescribed diabetes drugs, may have a new, hidden benefit: reducing the risk of dying from some cancers in postmenopausal women with type 2 diabetes, HealthDay reports. These findings are from a new study in International Journal of Cancer, which found that for women with type 2 diabetes and cancer...
Share

Certain Thyroid Tumor No Longer Considered Cancer

When is thyroid cancer not thyroid cancer? When a prestigious international panel of doctors decides that it’s not cancer. According to a story reported in today’s New York Times, this new reclassification will affect about 10,000 of 65,000 thyroid cancer patients in the U.S. alone. This decision and the science behind it was reported Thursday...